Ari Shomair
Corporate Officer/Principal presso POINT Biopharma, Inc. (United States)
Posizioni attive di Ari Shomair
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Corporate Officer/Principal | - | - |
Storia della carriera di Ari Shomair
Precedenti posizioni note di Ari Shomair
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| POIT BIOP | Ufficiale delle Risorse Umane | - | 27/12/2023 |
| Public Communications Contact | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Human Resources Officer | 1 |
| Public Communications Contact | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| POIT BIOP | Health Technology |
| Aziende private | 1 |
|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
- Borsa valori
- Insiders
- Ari Shomair
- Esperienza
